Premenopausal salpingo-oophorectomy, recommended for BRCA1/2 PV carriers given their high ovarian cancer risk, has been variably associated with lower breast cancer risk (in range of 0.2–0.9) depending on the affected gene and age at surgery (34) and aligns with general population findings. This evidence concerns the gene BRCA1 and breast carcinoma.